Chronic Migraine in Children and Adolescents

Childhood and Adolescent Headache (S Evers, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Childhood and Adolescent Headache

Abstract

Chronic migraine is defined as having more than 15 headache days in a month, half of these showing migraine features, for at least 3 months. It is a chronic painful syndrome with aspects such as psychiatric comorbid, decreased quality of life, and environmental and intrinsic psychological factors that make face-to-face treatment difficult. Children and adolescent migraine differ from adults as a result of growing brain and evolving disorder. In this paper, we will emphasize the definition, diagnosis, epidemiology, burden of life, and management of chronic migraine in children and adolescent.

Keywords

Chronic migraine Children Diagnosis Management Burden 

Notes

Compliance with Ethical Standards

Conflict of Interest

Aynur Özge and Osman Özgür Yalın declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Sources of Funding

None

References

Papers of particular interest, published recently, have been highlighted as: • Of importance•• Of major importance

  1. 1.
    Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders. 3rd ed (beta version). Cephalalgia. 2013;33(9):629–808.CrossRefGoogle Scholar
  2. 2.
    Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, et al. (2012). One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012;13(2):147–57.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70.CrossRefPubMedGoogle Scholar
  4. 4.
    Lipton RB, Silberstein SD. Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention. Headache. 2015;55(2):103–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population‐based study. Headache. 2008;48(8):1157–68.CrossRefPubMedGoogle Scholar
  6. 6.
    Sanderson JC, Devine EB, Lipton RB, et al. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013;84:1309–17.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA. 2004;291(4):493–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache. 2005;45(1):3–13.CrossRefGoogle Scholar
  9. 9.
    Hershey AD, Powers SW, Bentti AL, LeCates S. Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology. 2001;56(8):1032–7.CrossRefPubMedGoogle Scholar
  10. 10.••
    Wöber-Bingöl Ç. Epidemiology of Migraine and Headache in Children and Adolescents. Curr Pain Headache Rep. 2013;17(6):1–11. This outstanding study analysis covers total 64 cross-sectional studies published in the past 25 years. This study provides review of latest epidemiological data of children and adolescents headache disorders and study enabled us to compare longitudinal course of prevalence of headache disorders.CrossRefGoogle Scholar
  11. 11.•
    Ozge A, Saşmaz T, Buğdaycı R, et al. The prevalence of chronic and episodic migraine in children and adolescents. Eur J Neurol. 2013;20(1):95–101. This is a school-based broad study and one of the few studies investigated comparison of episodic and chronic migraine clinical characteristics and prevalence. This study also provides knowledge chronicity related factors.CrossRefPubMedGoogle Scholar
  12. 12.
    Lipton RB, Manack A, Ricci JA, Chee E, Turkel CC, Winner P. Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C‐dAS). Headache. 2011;51(5):693–706.CrossRefPubMedGoogle Scholar
  13. 13.
    Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Primary headaches in childhood-A population based study. Cephalalgia. 2010;30(9):1056–64.CrossRefPubMedGoogle Scholar
  14. 14.
    Krogh AB, Larsson B, Linde M. Prevalence and disability of headache among Norwegian adolescents: A cross-sectional school-based study. Cephalalgia. 2015;0333102415573512.Google Scholar
  15. 15.
    Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;31:1116–30.Google Scholar
  16. 16.
    Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population Burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559–66.CrossRefPubMedGoogle Scholar
  17. 17.
    Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–32.CrossRefPubMedGoogle Scholar
  18. 18.
    Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46:1334–43.CrossRefPubMedGoogle Scholar
  19. 19.••
    Abu-Arafeh I, Razak S, Sivaraman B, et al. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088–97. This is an important study, provides detailed analysis of current research. Data contains results of 35 studies published since 1990 to 2007. This study captures readers to understanding of prevalence of primary headache in children and adolescents.CrossRefPubMedGoogle Scholar
  20. 20.
    Mehta S. Study of various social and demographic variables associated with primary headache disorders in 500 school-going children of central. India. J Pediatr Neurosci. 2015;10(1):13.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Wang SJ, Fuh JL, Lu SR. Chronic daily headache in adolescents An 8-year follow-up study. Neurology. 2009;73(6):416–22.CrossRefPubMedGoogle Scholar
  22. 22.
    Galinski M, Sidhoum S, Cimerman P, Perrin O, Annequin D, Tourniaire B. Early Diagnosis of Migraine Necessary in Children: 10-Year Follow-up. Pediatr Neurol. 2015;53(4):319–23.CrossRefPubMedGoogle Scholar
  23. 23.
    Gelfand AA. Migraine in young children. Dev Med Child Neurol. 2015;57(6):503.CrossRefPubMedGoogle Scholar
  24. 24.
    Mariani R, Torriero R, Capuano A, et al. Clinical characteristics of primary headaches in children younger than 6 years. Cephalalgia. 2015;35:7–7.Google Scholar
  25. 25.
    Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache. 2002;42(3):204–16.CrossRefPubMedGoogle Scholar
  26. 26.
    Battistella PA, Fiumana E, Binelli M, et al. Primary headaches in preschool age children: clinical study and follow‐up in 163 patients. Cephalalgia. 2006;26(2):162–71.CrossRefPubMedGoogle Scholar
  27. 27.
    De Carlo D, Toldo I, Dal Zotto L, et al. Osmophobia as an early marker of migraine: a follow-up study in juvenile patients. Cephalalgia. 2012;32(5):401–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Kienbacher CH, Wöber CH, Zesch HE, et al. Clinical features, classification and prognosis of migraine and tension‐type headache in children and adolescents: a long‐term follow‐up study. Cephalalgia. 2006;26(7):820–30.CrossRefPubMedGoogle Scholar
  29. 29.••
    Ozge A, Sasmaz T, Cakmak SE, Kaleağası H, Siva A. Epidemiological-based childhood headache natural history study: after an interval of six years. Cephalalgia. 2010;30(6):703–12. This school-based study includes results after an interval of six years. Study provides important data about natural history of childhood headache and one of the important studies showed evolution of headache types from migraine to tension type headache or vice versa.CrossRefPubMedGoogle Scholar
  30. 30.
    Anttila P. Tension-type headache in childhood and adolescence. Lancet Neurol. 2006;5(3):268–74.CrossRefPubMedGoogle Scholar
  31. 31.
    Iacovelli E, Tarantino S, De Ranieri C, et al. Psychophysiological mechanisms underlying spatial attention in children with primary headache. Brain Dev. 2012;34(8):640–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Özge A, Bugdayci R, Sasmaz T, Kaleagasi H, Karakelle A, Tezcan H, et al. The Sensitivity and Specificity of the Case Definition Criteria in Mersin. Cephalalgia. 2002;22(10):791–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Pacheva I, Milanov I, Ivanov I, Stefanov F. Evaluation of diagnostic and prognostic value of clinical characteristics of Migraine and Tension Type headache included in the diagnostic criteria for children and adolescents in International Classification of Headache Disorders-second edition. Int J Clin Pract. 2012;66(12):1168–77.CrossRefPubMedGoogle Scholar
  34. 34.
    Gelfand A. Migraine and childhood periodic syndromes in children and adolescents. Curr Opin Neurol. 2013;26(3):262–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Özge A, Öksüz N, Ayta S, et al. Atopic disorders are more common in childhood migraine and correlated headache phenotype. Pediatr Int. 2014;56(6):868–72.CrossRefPubMedGoogle Scholar
  36. 36.
    Bellini B, Arruda M, Cescut A, et al. Headache and comorbidity in children and adolescents. J Headache Pain. 2013;14(1):79.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5(2):148–57.PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Deprez L, Peeters K, Van Paesschen WV, et al. Familial occipitotemporal lobe epilepsy and migraine with visual aura: linkage to chromosome 9q. Neurology. 2007;68(23):1995–2002.CrossRefPubMedGoogle Scholar
  39. 39.
    Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002;6:486–91.CrossRefPubMedGoogle Scholar
  40. 40.
    Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Hershey AD, Powers SW, Nelson TD, et al. Obesity in the pediatric headache population: a multicenter study. Headache. 2009;49(2):170–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Oakley CB, Scher AI, Recober A, Peterlin BL. Headache and obesity in the pediatric population. Curr Pain Headache Rep. 2014;18(5):1–13.CrossRefGoogle Scholar
  43. 43.
    Aytaçoğlu H, Özge A, Köstekçi İ, Taşdelen B, Öksüz B, Toros F. The Effects of Daily Variables on Primary Headache Disorders in High-School Children; A Proposal For A Cut-off Value For Study/Leisure Time Regarding Headache Types. J Neurol Sci Turk. 2011;29:453–64.Google Scholar
  44. 44.
    Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche MA, Maynard MK. PedMIDAS development of a questionnaire to assess disability of migraines in children. Neurology. 2011;57(11):2034–9.CrossRefGoogle Scholar
  45. 45.
    Heyer GL, Merison K, Rose SC, Perkins SQ, Lee JM, Stewart WC. PedMIDAS-Based Scoring underestimates Migraine disability on Non-school Days. Headache. 2014;54(6):1048–53.CrossRefPubMedGoogle Scholar
  46. 46.
    Ferracini GN, Dach F, Speciali JG. Quality of life and health‐related disability in children with migraine. Headache. 2014;54(2):325–34.CrossRefPubMedGoogle Scholar
  47. 47.
    Masruha MR, Lin J, Minett TS, et al. (2012). Social anxiety score is high in adolescents with chronic migraine. Pediatr Int. 2012;54(3):393–6.CrossRefPubMedGoogle Scholar
  48. 48.
    Seshia SS. Chronic Daily headache in children and adolescents. Curr Pain Headache Rep. 2012;16(1):60–72.CrossRefPubMedGoogle Scholar
  49. 49.
    Rousseau-Salvador C, Amouroux R, Annequin D, Salvador A, Tourniaire B, Rusinek S. Anxiety, depression and school absenteeism in youth with chronic or episodic headache. Pain Res Manag. 2014;19(5):235.PubMedCentralPubMedGoogle Scholar
  50. 50.
    Slater SK, Kashikar-Zuck SM, Allen JR, et al. Psychiatric comorbidity in pediatric chronic daily headache. Cephalalgia. 2012;32:1116–22.PubMedCentralCrossRefPubMedGoogle Scholar
  51. 51.
    Gladstein J, Rothner AD. Chronic daily headache in children and adolescents. Semin Pediatr Neurol. 2010;17(2):88–92.CrossRefPubMedGoogle Scholar
  52. 52.
    De Angelis V, Cherubini F, Nigrelli G, Erbuto D, Marteletti P. Multimodal therapy in the management of MOH: 3 year experience. J Headache Pain. 2015;16:135.CrossRefGoogle Scholar
  53. 53.
    Guidetti V, Dosi C, Bruni O. The relationship between sleep and headache in children: implications for treatment. Cephalalgia. 2014;34(10):767–76.CrossRefPubMedGoogle Scholar
  54. 54.
    Sieberg CB, Huguet A, von Baeyer CL, Seshia S. Psychological interventions for headache in children and adolescents. Can J Neurol Sci. 2012;39(01):26–34.CrossRefPubMedGoogle Scholar
  55. 55.
    Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;478:117878: 11.Google Scholar
  56. 56.
    Miller VA, Palermo TM, Powers SW, Scher MS, Hershey AD. Migraine headaches and sleep disturbances in children. Headache. 2003;43(4):362–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Carod-Artal FJ. Tackling chronic migraine:current perspectives. J Pain Res. 2014;8(7):185–94.CrossRefGoogle Scholar
  58. 58.
    Straube A, Heinen F, Ebinger F, von Kries R. Headache in school children: prevalence and risk factors. Dtsch Arztebl Int. 2013;6(57):811–8.Google Scholar
  59. 59.
    Verotti A, Di Fonzo A, Penta L, Agostinelli S, Parisi P. Obesity and headache/migraine: the importance of weight reduction through lifestyle modifications. Biomed Res Int. 2014;2014:420858.Google Scholar
  60. 60.
    Gelfand AA, Goadsby PJ. Medication overuse in children and adolescents. Curr Pain Headache Rep. 2014;18(7):1–6.CrossRefGoogle Scholar
  61. 61.
    Ozge A, Termine C, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part I: diagnosis. J Headache Pain. 2011;12(1):13–23.PubMedCentralCrossRefPubMedGoogle Scholar
  62. 62.••
    Ozge A, Termine C, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain. 2011;12:25–34. This is an important guide specifically prepared for headache management in children and adolescents. Include specific tips for patient based management planning.PubMedCentralCrossRefPubMedGoogle Scholar
  63. 63.
    Eidlitz-Markus T, Dlugatch Y, Haimi-Cohen Y, Goldberg-Stern H, Zeharia A. Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline. Pediatr Neurol. 2012;46(6):345–9.CrossRefPubMedGoogle Scholar
  64. 64.
    Shamliyan TA, Kane RL, Ramakrishnan R, Taylor FR. Migraine in children: preventive pharmacologic treatments. Agency for Healthcare Research and Quality (US); 2013 Jun. Report No.: 13-EHC065-EF.Google Scholar
  65. 65.••
    Lewis D, Ashwal S, Hirtz AO, Yonker M, Silberstein S. Practice parameters: Pharmacological treatment of migraine headache in children and adolescents Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215–24. This paper authors reviews 166 articles related with acute and preventive pharmacological treatments of migraine in children and adolescents. This study provides important knowledge to clinician to maintain evidence based treatment for these patients.CrossRefPubMedGoogle Scholar
  66. 66.
    Dodick DW, Turkel CC, Degryse RE, et al. OnabotulinumtoxinA for treatment of Chronic Migraine: Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program. Headache. 2010;50(6):921–36.CrossRefPubMedGoogle Scholar
  67. 67.
    Kabbouche M, O’Brien H, Hershey AD. Onabotulinumtoxin A in Pediatric Chronic Daily Headache. Curr Neurol Neurosci Rep. 2012;12(2):114–7.CrossRefPubMedGoogle Scholar
  68. 68.
    Takmaz SA, Inan N, Uçler S, Yazar MA, Inan L, Başar H. Greater occipital nevre block in migraine headache: preliminary results of 10 patients. Agri. 2008;20(1):47–50.PubMedGoogle Scholar
  69. 69.
    Inan LE, Inan N, Karadaş Ö, et al. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study. Acta Neurol Scand. 2015;132(4):270–7.CrossRefPubMedGoogle Scholar
  70. 70.
    Gelfand AA, Reider AC, Goadsby PJ. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol. 2014;50(2):135–9.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Neurology DepartmentMersin University School of MedicineMersinTurkey
  2. 2.Neurology DepartmentIstanbul Education and Research HospitalIstanbulTurkey

Personalised recommendations